Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND-1: Mazdutide for Weight Maintenance in Obesity
NCT07517042Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Modality
- Hormonal Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of mazdutide in obesity (4 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Percentage change of body weight at 52 weeks. Started Jun 2026; status: recruiting.
02
Drugs
mazdutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07517042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07517042.